Lunit Unveils Real-World Data Backing Clinical Efficacy of AI for the First Time in Breast Cancer Research; Abstracts to be Presented at RSNA 2022
/PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of AI-powered cancer solutions, today announced that it unveiled real-world data (RWD) validating the...
Source: prnewswire.com